Patents by Inventor Franz Birke

Franz Birke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sulphoxybenzamides
    Publication number: 20020161043
    Abstract: The present invention relates to new sulphoxybenzamides of general formula I, processes for preparing them as well as their use as medicaments.
    Type: Application
    Filed: October 23, 2001
    Publication date: October 31, 2002
    Inventors: Ralf Anderskewitz, Kurt Schromm, Franz Birke, Hans Michael Jennewein
  • Use of an LTB4 antagonist for the treatment or prevention of diseases caused by increased expression of mucin genes
    Publication number: 20020137792
    Abstract: Medicaments and pharmaceutical kits comprising an LTB4 antagonist of formula (I) 1
    Type: Application
    Filed: January 16, 2002
    Publication date: September 26, 2002
    Inventors: Ralf Anderskewitz, Christopher J. Montague Meade, Franz Birke, Hans Michael Jennewein, Birgit Jung
  • Pyranoside derivatives
    Publication number: 20020128209
    Abstract: The present invention relates to new pyranoside derivatives of general formula I, processes for preparing them as well as their use as medicaments.
    Type: Application
    Filed: October 23, 2001
    Publication date: September 12, 2002
    Inventors: Ralf Anderskewitz, Kurt Schromm, Franz Birke, Hans Michael Jennewein
  • Benzylamine and phenylethylamine derivatives, processes for preparing the same and their use as medicaments
    Patent number: 6288277
    Abstract: The present invention relates to new phenylamine derivatives, processes for preparing them and their use as pharmaceutical compositions.
    Type: Grant
    Filed: April 3, 2000
    Date of Patent: September 11, 2001
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Ralf Anderskewitz, Kurt Schromm, Ernst-Otto Renth, Franz Birke, Hans Michael Jennewein, Christopher John Montague Meade
  • Benzamidine derivatives and the use thereof as medicaments with LTB4-antagonistic effect
    Patent number: 6265612
    Abstract: The present invention relates to new benzamidine derivatives, processes for preparing them and their use in pharmaceutical compositions.
    Type: Grant
    Filed: December 1, 2000
    Date of Patent: July 24, 2001
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Kurt Schromm, Ralf Anderskewitz, Ernst-Otto Renth, Franz Birke, Hans Michael Jennewein, Christopher John Montague Meade
  • Benzamidine derivatives and the use thereof as medicaments with LTB4-antagonistic effect
    Patent number: 6197824
    Abstract: Novel benzamidines, having LTB4-antagonistic activity, of the formula methods for their preparation, their and their use as medicaments.
    Type: Grant
    Filed: June 2, 2000
    Date of Patent: March 6, 2001
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Kurt Schromm, Ralf Anderskewitz, Ernst-Otto Renth, Franz Birke, Hans Michael Jennewein, Christopher John Montague Meade
  • Pyranoside derivatives
    Patent number: 6197753
    Abstract: Pyranoside derivatives of the formula I wherein 1, m and n independently of one another denote an integer chosen from 0, 1, 2, 3 and 4 and 1+m+n≦4. These are are LTB4-antagonists. Also disclosed are processes for making these compounds.
    Type: Grant
    Filed: March 8, 1999
    Date of Patent: March 6, 2001
    Assignee: Boehringer Ingelheim KG
    Inventors: Ralf Anderskewitz, Kurt Schromm, Ernst-Otto Renth, Franz Birke, Hans M. Jennewein, Christopher J. M. Meade, Andreas Ding
  • Phenylethylamine derivatives, processes for preparing them and their use as pharmaceutical compositions
    Patent number: 6133479
    Abstract: The present invention relates to new phenylethylamine derivatives, processes for preparing them and their use as pharmaceutical compositions.
    Type: Grant
    Filed: July 29, 1999
    Date of Patent: October 17, 2000
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Ralf Anderskewitz, Franz Birke, Hans M. Jennewein
  • Phenylamidine derivatives, a process for preparing the same and their use as medicaments
    Patent number: 6127423
    Abstract: The invention relates to new phenylamidine derivatives, processes for preparing them and their use as pharmaceutical compositions.
    Type: Grant
    Filed: July 31, 1998
    Date of Patent: October 3, 2000
    Assignee: Boehringer Ingelheim KG
    Inventors: Ralf Anderskewitz, Kurt Schromm, Ernst-Otto Renth, Franz Birke, Hans Michael Jennewein, Christopher John Montague Meade, Andreas Ding
  • Amidine derivatives, the preparation and use thereof as medicaments with LTB4 antagonistic effect
    Patent number: 6037377
    Abstract: Compounds of the formula ##STR1## which is explained more fully in the specification, may be prepared by conventional methods and used therapeutically in conventional galenic preparations.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: March 14, 2000
    Assignee: Boehringer Ingelheim KG
    Inventors: Ralf Anderskewitz, Kurt Schromm, Ernst-Otto Renth, Frank Himmelsbach, Franz Birke, Armin Fugner
  • Acylamino-substituted hetrazepines
    Patent number: 5753647
    Abstract: A hetrazepine of the formula given below and a pharmaceutical composition comprising a therapeutically effective amount of the hetrazepine and a pharmaceutically acceptable inert carrier are disclosed and are useful in treating disease in a warm-blooded animal induced by endogenously formed PAF; ##STR1## wherein the substituents are defined herein.
    Type: Grant
    Filed: December 5, 1994
    Date of Patent: May 19, 1998
    Assignee: Boehringer Ingelheim KG
    Inventors: Karl-Heinz Weber, Werner Stransky, Ulrike Kufner-Muhl, Hubert Heuer, Franz Birke
  • Substituted benzamidine compounds which have useful pharmaceutical activity
    Patent number: 5731332
    Abstract: Compounds of formula ##STR1## and their therapeutic use, inter alia, as LTB.sub.4 -antagonists. Exemplary compounds are:(Methoxycarbonyl-imino-{4'-?2-(2-propylphenoxy)-ethoxy!-biphenyl-4-yl}-meth yl)-amine;(Benzyloxycarbonyl-imino-{4'-?2-(2-propylphenoxy)-ethoxy!-biphenyl-4-yl}-me thyl-amine;?Hydroxy-imino-(4-{3-?4-(1-methyl-1-phenylethyl)-phenoxymethyl!-benzoyloxy} phenyl)-methyl!-amine;?Ethoxycarbonyl-imino-(4-{3-?4-(1-methyl-1-phenylethyl)-phenoxymethyl!-benz oyloxy}phenyl)-methyl!-amine; and,?3'-Pyridylcarbonyl-imino-(4-{3-?4-(1-methyl-1-phenylethyl)-phenoxymethyl!- benzyloxy}phenyl)-methyl!-amine.
    Type: Grant
    Filed: March 28, 1997
    Date of Patent: March 24, 1998
    Assignee: Boehringer Ingelheim KG
    Inventors: Ralf Anderskewitz, Kurt Schromm, Ernst-Otto Renth, Franz Birke, Armin Fugner, Hubert Heuer, Christopher Meade
  • Hetrazepinoid amides
    Patent number: 5698552
    Abstract: The present invention relates to thienodiazepines of formula Ib: ##STR1## wherein U, V, R.sub.5, R.sub.6 and R.sub.7 are as defined herein. This invention also relates to processes for preparing these thienodiazepines and their use in pharmaceutical compositions with PAF-antagonistic activity.
    Type: Grant
    Filed: May 31, 1995
    Date of Patent: December 16, 1997
    Assignee: Boehringer Ingelheim KG
    Inventors: Karl-Heinz Weber, Werner Stransky, Ulrike Kufner-Muhl, Hubert Heuer, Franz Birke, Wolf-Dietrich Bechtel
  • Chemical compound, the preparation thereof and its use in pharmaceutical compositions
    Patent number: 5686496
    Abstract: The new compound of formula ##STR1## may be prepared by conventional methods and used therapeutically as an LTB.sub.4 -receptor antagonist.
    Type: Grant
    Filed: March 28, 1997
    Date of Patent: November 11, 1997
    Assignee: Boehringer Ingelheim KG
    Inventors: Ralf Anderskewitz, Kurt Schromm, Ernst-Otto Renth, Franz Birke, Armin Fugner, Hubert Heuer, Christopher Meade
  • New diazepines substituted in the 6-position, processes for their preparation and their use as pharmaceutical compositions
    Patent number: 5185442
    Abstract: The invention relates to new diazephines of the formula ##STR1## wherein R.sup.1, R.sup.2 and R.sup.3 are as defined herein, processes for preparing them and their use as pharmaceutical compositions useful for treating PAF-induced disease.
    Type: Grant
    Filed: January 15, 1992
    Date of Patent: February 9, 1993
    Assignee: Boehringer Ingelheim KG
    Inventors: Karl-Heinz Weber, Werner Stransky, Ulrike Kuefner-Muehl, Hubert Heuer, Franz Birke, Wolf-Dietrich Bechtel